PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Viral Infection, Department of Infection Control and Immunology, Ōmura Satoshi Memorial Institute & Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.\', \'Safety Science Laboratories, Kao Corporation, Tokyo, Japan.\', \'Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan.\', \'National Institute for Physiological Sciences, Okazaki, Japan.\', \'School of Veterinary Medicine, Kitasato University, Towada, Japan.\', \'Biological Science Laboratories, Kao Corporation, Wakayama, Japan.\', \'Epsilon Molecular Engineering Inc., Saitama, Japan.\', \'Department of Organoid Medicine, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1009542
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34648602
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all